Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
E. M. Choi, Boris Lacarra, M. Afolabi, B. Ale +35 more
2023Lancet Global Health15 citations Open access
Semantic Scholar

